Find a story
Search Spins
Search titles, summaries, and missing voices across published articles — press releases, announcements, and media coverage.
0 results for “Isomorphic Labs”
Google just announced a major shakeup of its top AI leadership
Google restructured its top AI leadership by appointing Demis Hassabis as chair of Google DeepMind and chief scientist of Alphabet, while promoting Koray Kavukcuoglu to SVP of DeepMind and retaining his role as chief AI architect.
Aug 5, 2026
The Isomorphic Labs Drug Design Engine unlocks a new frontier beyond AlphaFold
A Hacker News forum thread titled 'The Isomorphic Labs Drug Design Engine unlocks a new frontier beyond AlphaFold' features user comments discussing a claimed advance in AI-driven drug design, but contains no original reporting, technical details, or verifiable claims about the engine's capabilities or performance.
Jul 18, 2026
Google DeepMind and Isomorphic Labs launch a bioresilience program to leverage AI models for pathogen surveillance, vaccine design, and outbreak response (Madison Mills/Axios)
Google DeepMind and Isomorphic Labs jointly announced a new bioresilience program using AI models to support pathogen surveillance, vaccine design, and outbreak response — positioning AI as a proactive tool for global biological threat mitigation.
Jul 16, 2026
Our approach to bioresilience
Google DeepMind and Isomorphic Labs jointly announced a conceptual framework for 'bioresilience'—a term they define as using AI to strengthen biological systems against disruption—but provided no technical specifications, empirical validation, timelines, or independent verification.
Jul 16, 2026
How a Google DeepMind Spin-off Hunts Hidden Drug Targets
Isomorphic Labs, a Google DeepMind spin-off, launched its Isomorphic Drug Design Engine (IsoDDE) to improve AI-driven drug discovery by predicting protein-ligand interactions, pocket identification, and binding affinity—addressing limitations of AlphaFold3 in novel target spaces.
Published Jun 11, 2026 · Analyzed Jul 4, 2026